ABBV 250509 170.00C(ABBV250509C170000) Stock Price Today

18.10
-6.23-25.61%

15min DelayClose May 7 16:00 ET

18.12High18.10Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Moomoo Breakfast US

Apr 20 16:31

Columns What to Expect in the Week Ahead (Tesla, Alphabet Earnings; Global Flash PMI Reports)

Earnings Preview
Earnings season will intensify in the coming week, with reports expected from over 120 S&P 500 companies, including the Magnificent Seven's $Alphabet-A (GOOGL.US)$ $Alphabet-C (GOOG.US)$ and $Tesla (TSLA.US)$.
Elon Musk's electric vehicle company Tesla, which reports results on Tuesday after the close, is in the spotlight partly due to the billionaire's close ties to Trump. Alphabet is set to report...

US eases self-driving regulations: Can Tesla ride the policy wave to soar?

AMC Forever

Apr 11 00:13

Time to Buyyyyy!!!

$AbbVie (ABBV.US)$
This company's major earnings and factories are all within US. This should be more solid than those like MRK or JNJ if Trump does do the drug tariffs

Movers and Shakers

Apr 9 20:20

Columns Today's Pre-Market Movers and Top Ratings | BTU, CALM, ABBV and More

Morning Movers
Gapping Up
$Peabody Energy (BTU.US)$ shares extended gains to 11.10% in pre-market trading after a 9.2% rise yesterday, following President Trump's executive orders aimed at reviving the U.S. coal industry. Trump plans to use the Defense Production Act to support coal mining and next-generation technologies, and instruct the DOJ to challenge regulations affecting coal jobs, aiming to enhance U.S. AI leadership by b...

Teddy123

Apr 8 14:17

AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis

$AbbVie (ABBV.US)$
What are the key efficacy results of RINVOQ (ABBV) in treating giant cell arteritis?
RINVOQ showed 46.4% sustained remission rate at week 52 vs 29.0% for placebo, with 34.3% disease flare rate vs 55.6% for placebo, and 37.1% sustained complete remission vs 16.1% for placebo.
How does RINVOQ reduce steroid dependency in GCA patients?
RINVOQ demonstrated...

Investing with moomoo

Apr 1 18:42

Columns The Whole World Is Waiting for Trump to Wield the Tariff Stick. Here's What You Need to Know

President Donald Trump is gearing up to unveil a significant new set of import tariffs, which he refers to as “Liberation Day,”scheduled to commence this Wednesday (or Tuesday evening). The forthcoming announcement is poised to significantly intensify Trump's ongoing trade conflicts globally, with detailed information expected to be disclosed shortly.
On Monday, Trump suggested that he would be “very kind...

Trade talks sizzle: Market's next move?

ABBV250509C170000

News

Comments